Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: penicillins attending: chief complaint: esld in need of liver transplant major surgical or invasive procedure: : orthotopic liver transplant history of present illness: 46y man with liver failure secondary to hcv and alcoholic cirrhosis, portal hypertension, and hcc who presents for liver transplant. he has been feeling well and denies fever, chills, abdominal pain, shortness of breath, or chest pain. past medical history: cirrhosis hcv/etoh dx s/p failed pef-interferon tx for hcv h/o variceal hemorrhage social history: former etoh - dry x 4 years, h/o ivdu but currently clean family history: nc physical exam: vs: 99.2 78 122/69 20 98%ra wt 87.8kg gen: nad heart: regular, s1 s2 lungs: cta b/l, no wheeze or rales abd: soft, mild tenderness at umbilical hernia, non-distended, bowel sounds present extr: warm, well perfused, no edema pertinent results: on admission: wbc-4.4# rbc-4.45* hgb-14.6 hct-42.3 mcv-95 mch-32.8* mchc-34.6 rdw-14.8 plt ct-46* glucose-94 urean-13 creat-0.9 na-135 k-3.7 cl-101 hco3-26 angap-12 pt-25.5* ptt-39.4* inr(pt)-2.5* albumin-3.3* calcium-8.3* phos-2.8 mg-1.7 brief hospital course: 46 y/o male admitted for liver transplant. the donor liver was from a 33-year-old 110 pound woman who died from a combination of an asthma attack and snorting heroin. the patient was made aware of the nature of the donor death. hepatitis c and hiv testing were negative. the patient was taken to the or on by dr and dr for liver transplant. he received induction immunosuppression consisting of cellcept and solumedrol. significant portal hypertension was noted, and the liver was found to be quite adherent. prior to surgery the patient was on coumadin for portal vein thrombus. at time of surgery there seemed to be a small clot in the portal vein, however, the vein itself was open. once opened it appeared to be a cavernous transformation of the vein and there was an excellent flow. the liver pinked up immediately and made bile on the table. the patient tolerated the procedure well and was transferred to the sicu, intubated. he was extubated on postop day 1, and transferred out of the sicu on postop day 2. prograf was initiated on pod 1, steroid taper continued and cellcept without notable side effect. urine output was appropriate and foley was removed without incident. jp drains outputs averaged 1-2 liters total daily requiring iv fluid replacements. jp drain bilirubins were 1.5 and 1.8. jp drainge decreased allowing for removal of the lateral drain was d/c'd on pod 6. he was seen and cleared by pt, ambulating without difficulty. he had return of bowel function and was tolerating diet without any issues. was consulted for hyperglycemia. nph (10 units)was addded in addition to sliding scale humalog insulin with improved glucose control. he received instructioin on glucose management and self administration. he was discharged to home in stable condition. medications on admission: lasix 40 mg once a day, lactulose titrated to bowel movements per day, nadolol 20 mg once a day, protonix 40 mg 1 twice a day, aldactone 100 mg once a day, carafate 10 cc by mouth 4 times a day, coumadin as directed (2.5 daily discharge medications: 1. insulin nph human recomb 100 unit/ml suspension sig: ten (10) units subcutaneous once a day: am dose. disp:*2 bottles* refills:*2* 2. prednisone 5 mg tablet sig: four (4) tablet po daily (daily): follow taper. 3. valganciclovir 450 mg tablet sig: two (2) tablet po daily (daily). 4. mycophenolate mofetil 500 mg tablet sig: two (2) tablet po bid (2 times a day). 5. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 6. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). 7. fluconazole 200 mg tablet sig: two (2) tablet po q24h (every 24 hours). 8. morphine 15 mg tablet sig: one (1) tablet po q4h (every 4 hours) as needed for pain. disp:*30 tablet(s)* refills:*0* 9. trimethoprim-sulfamethoxazole 80-400 mg tablet sig: one (1) tablet po daily (daily). 10. tacrolimus 1 mg capsule sig: four (4) capsule po q12h (every 12 hours) as needed for s/p liver transplant. 11. insulin nph human recomb 100 unit/ml suspension sig: ten (10) units subcutaneous once a day: at breakfast. disp:*1 vial* refills:*2* 12. insulin lispro 100 unit/ml solution sig: follow sliding scale units subcutaneous four times a day. disp:*1 vial* refills:*2* 13. one touch ultra system kit kit sig: one (1) miscellaneous four times a day. disp:*1 kit* refills:*2* 14. one touch ultrasoft lancets misc sig: one (1) miscellaneous four times a day. disp:*1 box* refills:*2* 15. one touch ultra test strip sig: one (1) in four times a day. disp:*1 box* refills:*2* discharge disposition: home with service facility: vna assoc. of discharge diagnosis: liver failure secondary to hcv and alcoholic cirrhosis, portal hypertension now s/p orthotopic liver transplant discharge condition: stable/good discharge instructions: please call the transplant clinic at if you fever greater than 101, chills, nausea, vomiting, diarrhea, constipation. monitor the incision for redness, drainage or bleeding drain and record jp drain output as often as needed. do not allow the bulb to become more than half full. bring a copy of the drain outputs to your clinic visit. labs to be drawn every monday and thursday. fax results to transplant clinic at . no heavy living you may shower, allow water to run over incision, pat incision dry. place new drain sponge following your shower or daily. no driving if taking narcotic pain medication followup instructions: , md phone: date/time: 8:30 , md phone: date/time: 9:30 , transplant social work date/time: 10:30 procedure: enteral infusion of concentrated nutritional substances other transplant of liver total hepatectomy other operations on lacrimal gland transplant from cadaver diagnoses: thrombocytopenia, unspecified tobacco use disorder adrenal cortical steroids causing adverse effects in therapeutic use chronic hepatitis c without mention of hepatic coma alcoholic cirrhosis of liver other and unspecified alcohol dependence, in remission portal hypertension long-term (current) use of insulin other sequelae of chronic liver disease personal history of venous thrombosis and embolism malignant neoplasm of liver, primary esophageal varices without mention of bleeding secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 

Answer: The patient is high likely exposed to